Combining biopsy tools improves mutation detection rate in central lung cancer

ERJ Open Res. 2020 Sep 14;6(3):00002-2020. doi: 10.1183/23120541.00002-2020. eCollection 2020 Jul.


In central exophytic lung cancer, the detection rate of oncogenic mutations and PDL1 positivity may be increased by combined sampling by forceps and EBUS-TBNA. The additional sampling of mediastinal lymph node and ctDNA may not be of additional benefit.